Synarel Articles
Recordati Sales Boost From Rx Abroad, Italian OTCs
7 August 1995
SYNTEX INVESTMENT FOR FUTURE GROWTH
29 June 1992
ITALY'S RECORDATI LOOKS FOR EXPANSION
15 June 1992
ARES SERONO - HOW TO PLAY THE STOCK
11 May 1992
SYNTEX "A COMPANY ON THE MOVE"
20 January 1992
Showing 1-6 of 6 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
